Globally, about 3.2 billion people – nearly half of the world’s population – are at risk of malaria. According to the World Malaria Report 2016, in 2015, there were 212 million new cases of malaria and 429,000 deaths. One child dies from malaria every two minutes.
Achieving more together with partners On World Malaria Day 2017 the Novartis Foundation recognizes the importance of partnerships as critical toward achieving the goal of ending malaria for good. This vision can only become reality with a truly multisector and multidisciplinary approach. At the Novartis Foundation, we see the value when different groups with complementing resources and expertise work together.
Interrupting transmission through contact tracing Together with our partners, we work to assess the impact, operational feasibility, safety and cost-effectiveness of Targeted Parasite Elimination (TPE), a promising new strategy to eliminate the “reservoir” of malaria parasites in a population at risk for malaria in a low transmission setting. The goal of the TPE program in Namibia is to define the optimal strategy to interrupt malaria transmission in the Zambezi region, which accounts for a third of the country’s malaria diagnoses. The program is designed to treat the person diagnosed with malaria and close contacts that may not have symptoms but can carry the parasite, and thereby contribute to ongoing transmission. Ultimately, the goal of this TPE strategy is to enable Namibia to evolve from a malaria pre-elimination stage to that of elimination.